Ergebnis der Suchanfrage nach Patient

Sysmex Europe SE

4

Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes

STADA Arzneimittel AG

Press release: Alvotech and STADA add to strategic alliance through denosumab partnership

Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...

Helmholtz Zentrum München

New Study: Father's Diet Before Conception Influences Children's Health

STADA Arzneimittel AG

Press release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo

STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...

Helmholtz Zentrum München

Press Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...

Deutsche Post DHL Group

PM: DHL Supply Chain erweitert Pharmalogistik-Geschäft in Frankreich / PR: DHL Supply Chain expands pharma logistics operations in France

Soterios Pharma

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

London (ots/PRNewswire) - - Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo ...

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK

Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...

ARTTIC Innovation GmbH

canSERV invites applications for "Revolutionising Cancer Patient Care"

ARTTIC Innovation GmbH

3

canSERV invites applications for "Revolutionising Cancer Patient Care"

Lifespin GmbH

Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

Istanbul and Regensburg, Germany (ots/PRNewswire) - lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized ...

Gerresheimer AG

Gerresheimer expands capacities for Medical Systems in the USA

Technische Universität München

Multi-purpose mucus - What mucins can do in medicine

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE What mucins can do in medicine Multi-purpose mucus They are in our eyes, on our tongues, and in our stomachs: Protective layers of mucus, a slime consisting primarily of mucins. These are molecules which bind water to form a natural lubricant. Researchers at the Technical University of Munich (TUM) use them to develop coatings for contact lenses and intubation tubes, healing ...

Helmholtz Zentrum München

New Study: Night-time heat significantly increases the risk of stroke

Helios Gesundheit

3

Seminar on Echocardiography: TEE Masterclass – live stream from the operating theatres of Leipzig Heart Center

Technische Universität München

GARMI care robot becomes a universal assistant

TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE From skill sets to an overall concept GARMI care robot becomes a universal assistant - At the International Conference on Robotics and Automation (ICRA2024) in Yokohama, Japan, geriatronics researchers from the Technical University of Munich (TUM) will present four new research projects - including work on gripping objects and new safety functionalities. - For the first time, ...

Bosch Healthcare Solutions GmbH

PCR rapid test for Candida auris for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of the multidrug-resistant fungus at the point of care

Waiblingen (ots) - - Vivalytic test detects Candida auris in under an hour at the point of care, making it the world’s first test suitable for screenings. - Candida auris infection rates are on the rise in Germany and can cause severe infections, for example of the bloodstream (sepsis). - Hospitals can use the new ...

ARTTIC Innovation GmbH

LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision

Medison Pharma; Alnylam Pharmaceuticals

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Zug, Switzerland (ots/PRNewswire) - - The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance - Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient ...

Gerresheimer AG

2

Gerresheimer partners with RxCap to offer connected adherence solutions

HUMA Therapeutics

Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients

London (ots/PRNewswire) - Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom. This collaboration underscores Merck KGaA, Darmstadt, Germany and Huma's ...

LEONINE Studios

Mediawan announces combination with LEONINE, one of the largest independent studios in the German-speaking market

Helmholtz Zentrum München

Advanced Brain Science Without Coding Expertise

Bosch Healthcare Solutions GmbH

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform

Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. - PCR test for multiresistant gram-negative (MRGN) ...

Messe Erfurt

3D Pioneers Challenge 2024 Finalists have been announced

Ottobock SE & Co. KGaA

3

Milestones in mobility - Ottobock at OTWorld 2024

Norgine B.V.

Norgine B.V. submits Marketing Authorisation Application via Project Orbis for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Amsterdam (ots/PRNewswire) - Norgine B.V. today announced its first marketing authorisation application submissions on 10 April 2024, seeking approval for eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone supports Norgine's efforts to ...

Helmholtz Zentrum München

Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease

Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American Journal of Respiratory and ...

Dr. Reddy's Laboratories SA

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment

InSightec

European Parliament Recognizes Essential Tremor as Official Disease in Ground-Breaking Declaration

Brussels (ots/PRNewswire) - The Insightec-organized conference resulted in a Joint Declaration, promising new hope for patients suffering from the condition The European Parliament, in collaboration with Insightec and patient advocacy groups, has taken a historic step forward in the healthcare realm by signing a ...